ES2975319T3 - Polimorfos y formas sólidas de un compuesto de pirimidinilamino-pirazol y métodos de producción - Google Patents

Polimorfos y formas sólidas de un compuesto de pirimidinilamino-pirazol y métodos de producción

Info

Publication number
ES2975319T3
ES2975319T3 ES18881859T ES18881859T ES2975319T3 ES 2975319 T3 ES2975319 T3 ES 2975319T3 ES 18881859 T ES18881859 T ES 18881859T ES 18881859 T ES18881859 T ES 18881859T ES 2975319 T3 ES2975319 T3 ES 2975319T3
Authority
ES
Spain
Prior art keywords
pyrimidinylamino
polymorphs
production methods
solid forms
pyrazole compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES18881859T
Other languages
English (en)
Inventor
Travis Remarchuk
Anantha Sudhakar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Denali Therapeutics Inc
Original Assignee
Denali Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denali Therapeutics Inc filed Critical Denali Therapeutics Inc
Application granted granted Critical
Publication of ES2975319T3 publication Critical patent/ES2975319T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES18881859T 2017-11-21 2018-11-20 Polimorfos y formas sólidas de un compuesto de pirimidinilamino-pirazol y métodos de producción Active ES2975319T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762589276P 2017-11-21 2017-11-21
PCT/US2018/062102 WO2019104086A1 (en) 2017-11-21 2018-11-20 Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production

Publications (1)

Publication Number Publication Date
ES2975319T3 true ES2975319T3 (es) 2024-07-04

Family

ID=66631734

Family Applications (1)

Application Number Title Priority Date Filing Date
ES18881859T Active ES2975319T3 (es) 2017-11-21 2018-11-20 Polimorfos y formas sólidas de un compuesto de pirimidinilamino-pirazol y métodos de producción

Country Status (23)

Country Link
US (3) US10370361B2 (es)
EP (1) EP3717473B1 (es)
JP (1) JP7303821B2 (es)
KR (1) KR20200089713A (es)
CN (1) CN111819174A (es)
AR (1) AR113893A1 (es)
AU (1) AU2018372180B2 (es)
BR (1) BR112020010215A2 (es)
CA (1) CA3083022A1 (es)
CL (1) CL2020001346A1 (es)
CO (1) CO2020006206A2 (es)
CR (1) CR20200216A (es)
EA (1) EA202091279A1 (es)
ES (1) ES2975319T3 (es)
IL (1) IL274824A (es)
JO (1) JOP20200128A1 (es)
MA (1) MA51222A (es)
MX (1) MX2020005332A (es)
PE (1) PE20210157A1 (es)
SG (1) SG11202004733WA (es)
TW (1) TWI823878B (es)
UA (1) UA126414C2 (es)
WO (1) WO2019104086A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020005332A (es) 2017-11-21 2021-01-08 Denali Therapeutics Inc Polimorfos y formas solidas de un compuesto de pirimidinilamino-pirazol y metodos de produccion.
MA51339A (fr) 2017-12-20 2020-10-28 Denali Therapeutics Inc Procédé de préparation de composés pyrimidinyl-4-aminopyrazole
WO2023174946A1 (en) 2022-03-15 2023-09-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Early and non-invasive method for assessing a subject's risk of having parkinson's disease

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2574168B9 (en) 2010-05-21 2016-10-05 Incyte Holdings Corporation Topical formulation for a jak inhibitor
CN103038230B (zh) 2010-06-04 2016-05-25 霍夫曼-拉罗奇有限公司 作为lrrk2调节剂的氨基嘧啶衍生物
GB201015949D0 (en) 2010-09-22 2010-11-03 Medical Res Council Technology Compounds
JP5986094B2 (ja) * 2010-11-10 2016-09-06 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Lrrk2調節薬としてのピラゾールアミノピリミジン誘導体
BR112014011219B1 (pt) 2011-11-29 2022-08-23 Genentech, Inc. Derivados de aminopirimidina, seus usos, e composição farmacêutica
PT2785711T (pt) 2011-11-29 2016-09-30 Hoffmann La Roche Derivados de 2-(fenil ou pirid-3- il)aminopiridinacomo moduladores de lrrk2 quinase, para o tratamento da doença de parkinson
BR112014011850B1 (pt) 2011-11-29 2022-01-11 Genentech, Inc Derivados de aminopirimidina, seus usos, e composição farmacêutica
AR089182A1 (es) 2011-11-29 2014-08-06 Hoffmann La Roche Derivados de aminopirimidina como moduladores de lrrk2
MX363118B (es) 2012-05-03 2019-03-11 Genentech Inc Derivados de pirazol aminopirimidina como moduladores de cinasa 2 de repeticion rica en leucina (lrrk2).
EP2844658B1 (en) 2012-05-03 2019-03-20 Genentech, Inc. Pyrazole aminopyrimidine derivatives as lrrk2 modulators for use in the treatment of parkinson's disease
CN114315819A (zh) 2016-06-16 2022-04-12 戴纳立制药公司 作为用于治疗神经退化性病症的lrrk2抑制剂的嘧啶-2-基氨基-1h-吡唑
MX2020005332A (es) * 2017-11-21 2021-01-08 Denali Therapeutics Inc Polimorfos y formas solidas de un compuesto de pirimidinilamino-pirazol y metodos de produccion.

Also Published As

Publication number Publication date
JOP20200128A1 (ar) 2020-05-21
US20190194170A1 (en) 2019-06-27
TW201925190A (zh) 2019-07-01
JP7303821B2 (ja) 2023-07-05
BR112020010215A2 (pt) 2020-11-03
IL274824A (en) 2020-07-30
CN111819174A (zh) 2020-10-23
CO2020006206A2 (es) 2020-08-10
MA51222A (fr) 2020-10-07
UA126414C2 (uk) 2022-09-28
WO2019104086A1 (en) 2019-05-31
CL2020001346A1 (es) 2020-11-20
MX2020005332A (es) 2021-01-08
AU2018372180A1 (en) 2020-06-18
EA202091279A1 (ru) 2020-08-19
AR113893A1 (es) 2020-06-24
US20190315723A1 (en) 2019-10-17
TWI823878B (zh) 2023-12-01
AU2018372180B2 (en) 2023-08-17
CA3083022A1 (en) 2019-05-31
US11427571B2 (en) 2022-08-30
CR20200216A (es) 2021-03-19
SG11202004733WA (en) 2020-06-29
JP2021504450A (ja) 2021-02-15
EP3717473B1 (en) 2024-01-10
EP3717473A1 (en) 2020-10-07
EP3717473A4 (en) 2021-07-07
US10851088B2 (en) 2020-12-01
US10370361B2 (en) 2019-08-06
PE20210157A1 (es) 2021-01-26
KR20200089713A (ko) 2020-07-27
US20210087176A1 (en) 2021-03-25

Similar Documents

Publication Publication Date Title
ES2975263T3 (es) Formas cristalinas de un compuesto triazolopirimidínico
DK3411212T3 (da) Fremgangsmåde til fremstilling af en drivrem
ZA201906944B (en) Methods of manufacturing of niraparib
DK3152022T3 (da) Fremgangsmåde til fremstilling af en gipsplade og den gipsplade som opnås derved
GB201716774D0 (en) Method of manufacturing fluorescent-material-containing member
ES2975319T3 (es) Polimorfos y formas sólidas de un compuesto de pirimidinilamino-pirazol y métodos de producción
PL3272616T3 (pl) Sposób montażu pojazdu kolejowego
DK3430004T3 (da) Faststofformer af nilotinibsalte
PL3755681T3 (pl) Sposób wytwarzania 4-boronofenyloalaniny
GB2548706B (en) Method of manufacturing fluorescent-material-containing member
GB2552815B (en) Method of manufacturing a tubular member
TWI800526B (zh) 合成皮革之製造方法
BR112017009048A2 (pt) método de revestimento de uma estrutura tubular
DK3652187T3 (da) Forbedret fremgangsmåde til fremstilling af imetelstat
BR112017015822A2 (pt) método para fabricação de junta flutuante e junta flutuante fabricada pelo referido método
IT201700098782A1 (it) Metodo di realizzazione di un pannello termico-fotovoltaico
DK3442995T3 (da) Produktion af suberin
DK3319924T3 (da) Fremgangsmåde til fremstilling af en plade
GB201601249D0 (en) Production of manool
DK3612553T3 (da) Forbedret fremgangsmåde til højniveauproduktion af crm
DK3485300T3 (da) Fremgangsmåde til at kendetegne en metallisk interferensmasse
DK3215707T3 (da) Fremgangsmåde til at fremstille et sidelomme-dornelement
DK3280704T3 (da) Fremgangsmåde til syntese af en prækursor af en enkelt isomer af dairy-lacton
ITUB20152081A1 (it) Procedimento di produzione di un diffusore e corrispondente diffusore
GB201818298D0 (en) Method of manufacturing structures